C-reactive protein and the risk of developing hypertension

被引:787
作者
Sesso, HD
Buring, JE
Rifai, N
Blake, GJ
Gaziano, JM
Ridker, PM
机构
[1] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Dept Med, Boston, MA 02215 USA
[2] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA
[3] Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Dept Med, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[6] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 290卷 / 22期
关键词
D O I
10.1001/jama.290.22.2945
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Although it has been hypothesized that hypertension is in part an inflammatory disorder, clinical data linking inflammation with incident hypertension are scarce. Objective To examine whether C-reactive protein levels, a marker of systemic inflammation, are associated with incident hypertension. Design, Setting, and Participants A prospective cohort study that began in 1992 of 20525 female US health professionals aged 45 years or older who provided baseline blood samples with initially normal levels of blood pressure (BP) (systolic BP <140 mm Hg and diastolic BP <90 mm Hg, and no history of hypertension or antihypertensive medications) and then followed up for a median of 7.8 years for the development of incident hypertension. Plasma C-reactive protein levels were measured and baseline coronary risk factors were collected. Main Outcome Measure Incident hypertension, defined as either a new physician diagnosis, the initiation of anti hypertensive treatment, or self-reported systolic BP of at least 140 mm Hg or a diastolic BP of at least 90 mm Hg. Results During follow-up, 5365 women developed incident hypertension. In crude models, the relative risks (RRs) and 95% confidence intervals (Cis) of developing hypertension from the lowest (referent) to the highest levels of baseline C-reactive protein were 1.00, 1.25 (95% CI, 1.14-1.40)', 1.51 (95% Cl, 1.35-1.68), 1.90 (95% Cl, 1 ' 72-2.11), and 2.50 (95% Cl, 2.27-2.75) (linear trend P<.001). In fully adjusted models for coronary risk factors, the RRs and 95% Cis were 1.00, 1.07 (95% Cl, 0.95-1.20), 1.17 (95% Cl, 1.04-1.31), 1.30 (95% Cl, 1.17-1.45), and 1.52 (95% Cl, 1.36-1.69) (linear trend P<.001). C-reactive protein was significantly associated with an increased risk of developing hypertension in all prespecified subgroups evaluated, including those with very low levels of baseline BP, as well as those with no traditional coronary risk factors. Similar results were found when treating C-reactive protein as a continuous variable and controlling for baseline BP. Conclusion C- reactive protein levels are associated with future development of hypertension, which suggests that hypertension is in part an inflammatory disorder.
引用
收藏
页码:2945 / 2951
页数:7
相关论文
共 37 条
  • [1] Is C-reactive protein an independent risk factor for essential hypertension?
    Bautista, LE
    López-Jaramillo, P
    Vera, LM
    Casas, JP
    Otero, AP
    Guaracao, AI
    [J]. JOURNAL OF HYPERTENSION, 2001, 19 (05) : 857 - 861
  • [2] Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women
    Bermudez, EA
    Rifai, N
    Buring, J
    Manson, JE
    Ridker, PA
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) : 1668 - 1673
  • [3] Vascular inflammation and the renin-angiotensin system
    Brasier, AR
    Recinos, A
    Eledrisi, MS
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (08) : 1257 - 1266
  • [4] Blood pressure and inflammation in apparently healthy men
    Chae, CU
    Lee, RT
    Rifai, N
    Ridker, PM
    [J]. HYPERTENSION, 2001, 38 (03) : 399 - 403
  • [5] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [6] VALIDATION OF QUESTIONNAIRE INFORMATION ON RISK-FACTORS AND DISEASE OUTCOMES IN A PROSPECTIVE COHORT STUDY OF WOMEN
    COLDITZ, GA
    MARTIN, P
    STAMPFER, MJ
    WILLETT, WC
    SAMPSON, L
    ROSNER, B
    HENNEKENS, CH
    SPEIZER, FE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 123 (05) : 894 - 900
  • [7] Effect of postmenopausal hormones on inflammation-sensitive proteins - The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
    Cushman, M
    Legault, C
    Barrett-Connor, E
    Stefanick, ML
    Kessler, C
    Judd, HL
    Sakkinen, PA
    Tracy, RP
    [J]. CIRCULATION, 1999, 100 (07) : 717 - 722
  • [8] THE STATUS OF PAI-1 AS A RISK FACTOR FOR ARTERIAL AND THROMBOTIC DISEASE - A REVIEW
    DAWSON, S
    HENNEY, A
    [J]. ATHEROSCLEROSIS, 1992, 95 (2-3) : 105 - 117
  • [9] C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells
    Devaraj, S
    Xu, DY
    Jialal, I
    [J]. CIRCULATION, 2003, 107 (03) : 398 - 404
  • [10] Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins
    Engström, G
    Janzon, L
    Berglund, G
    Lind, P
    Stavenow, L
    Hedblad, B
    Lindgärde, F
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (12) : 2054 - 2058